1: pembrolizumab [Supplementary Concept]

Date introduced: July 16, 2014
Registry Number: DPT0O3T46P
Heading Mapped to:
    Antibodies, Monoclonal, Humanized

Entry Terms:
    MK-3475
    Keytruda
    lambrolizumab
    SCH-900475

Previous Indexing:
    ANTIBODIES, MONOCLONAL (2014-2015)

Pharmacologic Action:
    Antineoplastic Agents, Immunological
    Immune Checkpoint Inhibitors